[1]
Andy Andy and Robertus Bebet Prasetyo, “Prostate-Specific Antigen Levels of Prostate Cancer Patients Three Months Following LHRH Agonist Therapy”, GJMR, vol. 19, no. F6, pp. 17–20, May 2019.